Aviva’s (AV) “Overweight” Rating Reaffirmed at JPMorgan Chase & Co.

Aviva (LON:AV)‘s stock had its “overweight” rating reaffirmed by JPMorgan Chase & Co. in a report issued on Tuesday, MarketBeat Ratings reports. They presently have a GBX 615 ($7.74) price target on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 21.54% from the company’s previous close.

Separately, Deutsche Bank Aktiengesellschaft restated a “top pick” rating on shares of Aviva in a research report on Friday, December 6th. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of GBX 579 ($7.29).

Aviva Price Performance

Shares of AV opened at GBX 506 ($6.37) on Tuesday. The firm has a market capitalization of £13.60 billion, a PE ratio of 10.43, a price-to-earnings-growth ratio of 2.01 and a beta of 0.89. The company has a debt-to-equity ratio of 68.87, a current ratio of 2.93 and a quick ratio of 1.57. Aviva has a 1-year low of GBX 390.70 ($4.92) and a 1-year high of GBX 510.20 ($6.42). The company’s fifty day moving average price is GBX 487.69 and its 200-day moving average price is GBX 484.31.

Insider Activity at Aviva

In other news, insider Pippa Lambert acquired 988 shares of the firm’s stock in a transaction on Friday, December 27th. The stock was acquired at an average price of GBX 465 ($5.85) per share, for a total transaction of £4,594.20 ($5,781.05). 0.17% of the stock is currently owned by insiders.

About Aviva

Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.